CMS transparency rules and AI could bring “Expedia-like” drug price comparisons for consumers, but payer compliance to transparency rules remains low.
News|Articles|May 1, 2002
Thrombolytics after acute myocardial infarction (MI) may not be goodfor elderly patients.
Even when very elderly (age 80 years and older)patients have no contraindications to thrombolytic therapy, treatment withthese drugs can increase their risk of death.
Advertisement
Advertisement
Related to this article
A new Spherix Global Insights survey shows providers want administrative support for prior authorization while patients prioritize access and affordability
Pharmacy benefit managers are moving beyond formulary access to provide support programs for women's health. Here's how three PBMs — Judi Health, LucyRx and RxPreferred — are putting that strategy into practice.
Women face more gaps in healthcare than men, from missed screenings, undertreatment and biased coverage. PBMs are launching programs to address some of the gaps.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Why consumers still can’t comparison shop for medication
2
Teledentistry is a step in closing the gap in dental care
3
Low birth volume, finances tied to hospital obstetric unit closures
4
Heather Burrell Ward, M.D., on personalizing TMS in schizophrenia
5